Navigation Links
AMRI Announces President for AMRI Europe
Date:5/22/2012

s space with key relationships in the European and North American healthcare community.  His unique insights are a good fit with our AMRI SMARTSOURCING™ brand and I look forward to his contributions in building strategic relationships with a broader customer base, which benefits all of our locations."

Mr. Shott's earlier career included executive board posts at RhodiaChirex in France, Chirex in the United States, Lonza in Switzerland, and Astra Zeneca in the United Kingdom. He has been particularly involved in creating and/or transforming businesses by a combination of break out development, culture change, organic growth, internal re-engineering and external merger, acquisition and divestment.

Mr. Shott said, "I believe AMRI has assembled a highly distinctive combination of skills, capabilities and capacities across three continents and can provide unparalleled solutions to customer needs. I am extremely excited at helping to develop business in Europe in a rapidly changing business environment."

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 21 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.

AMRI UK provides development and manufacturing services, including pre-clinical and P
'/>"/>

SOURCE AMRI
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
2. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
3. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
4. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
5. Cerecor Announces Initiation of CLIN01-002-A
6. Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
7. Digestive Care, Inc. Announces FDA Approval of PERTZYE™ (pancrelipase) Delayed-Release Capsules
8. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
9. Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent
10. Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout
11. Pennsylvania DEP Announces X-ray Registration Fee Amnesty Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
(Date:7/9/2014)... the Perelman School of Medicine at the University of ... have received an $8 million grant from the National ... light therapy (PDT) in patients with malignant pleural mesothelioma, ... manifests itself in the lining of the lungs and ... grant will fund a clinical trial and additional studies ...
(Date:7/9/2014)... metabolism of stromal support cells and immune cells ... types in the development of diseases could open ... That was the conclusion of a review article by ... journal Nature . , Prof. Peter Carmeliet: "Consider ... metabolism of cancer cells has been examined in minute ...
(Date:7/9/2014)... personal and subjective, the human brain turns them ... across different senses, situations and even people, reports ... Anderson. , "We discovered that fine-grained patterns of ... of the brain associated with emotional processing, act ... subjective feeling," says Anderson, associate professor of human ...
(Date:7/9/2014)... for more than watching World Cup highlights, Brian Williams ... landing in unfortunate positions on railings. A University of ... Online Journal shows that YouTube also allows researchers, ... public on topics of skin cancer and prevention. , ... the future of how we communicate around the world," ...
(Date:7/9/2014)... labels handed out by pharmacists may be misread ... according to new research by the University of ... Blind)., The study, published recently in the ... prescription medications dispensed by pharmacies do not consistently ... simply following recommended guidelines for font size, use ...
Breaking Medicine News(10 mins):Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Wake-up call for more research into cell metabolism 2Health News:Study cracks how the brain processes emotions 2Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... conference organized in London by the Breast Cancer Campaign charity ... killer disease. //Instead it may become a long-term manageable disorder ... breast cancer patients has increased due to the significant developments ... revealed at the conference that the recurrence of the cancer ...
... with medical consultations and patients are seen tapping the ... medial ailments, especially ones they would like to hide ... infections scored very high on the search list and ... share of attention.NHS direct, the helpline is known to ...
... treatment was potentially beneficial in slowing and preventing ... (AMD). A recent study, the Complications of Age-Related ... from the National Eye Institute (NEI) of the ... laser treatment is ineffective in preventing complications of ...
... A recent research has found that more stress can lead ... restrain the cancer. //, ,A remarkable finding suggests that ... growth of cancer. Norepinephrine, a hormone released during stress stimulates ... tissue around tumor cells. This enables the cells to move ...
... a drug commonly prescribed to treat seizures and migraine ... stones//, researchers at UT Southwestern Medical Center have found. ... how the long-term use of topiramate affects kidney-stone formation ... Journal of Kidney Diseases. ,Several case reports ...
... major depression can become symptom-free if they are willing ... to determine which work best for them, which may ... the mix. ,The largest study on treatments for ... 67 percent of patients achieved a full remission of ...
Cached Medicine News:Health News:Breast Cancer may no longer be a killer disease 2Health News:People with early AMD not benefited by Laser Treatment 2Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 2Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 3Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 3
Sabre 180, 230V, 50Hz is a powerful niche generator....
High performance capabilities in a multipurpose generator, blended cut modes, simultaneous independent coagulation, low voltage coagulation, valleylab REM safety substantially reduces the risk of pat...
Lorgnette pinhole occluder...
Black multi-pinhole occluder...
Medicine Products: